Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Adrenal Cortex Carcinoma
Drug:
cisplatin
(
DNA synthesis inhibitor
) +
doxorubicin hydrochloride
(
Topoisomerase II inhibitor
) +
etoposide IV
(
Topoisomerase II inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Adrenocortical carcinoma: Systemic therapy for locoregional unresectable/metastatic adrenocortical carcinoma…preferred regimens…Cisplatin + etoposide + doxorubicin
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login